Adamis Pharmaceuticals Corporation (ADMP)
| Market Cap | 106.50M |
| Revenue (ttm) | 12.52M |
| Net Income (ttm) | -57.42M |
| Shares Out | 148.89M |
| EPS (ttm) | -0.42 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 974,702 |
| Open | 0.720 |
| Previous Close | 0.713 |
| Day's Range | 0.710 - 0.735 |
| 52-Week Range | 0.480 - 2.340 |
| Beta | 1.31 |
| Analysts | Buy |
| Price Target | 1.00 (+39.8%) |
| Earnings Date | n/a |
About ADMP
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy and respiratory disease in the United States. The company's product candidates comprise Symjepi Injection pre-filled syringe (PFS) for use in the emergency treatment of acute allergic reactions, including anaphylaxis; dry powder inhaler products consisting of fluticasone for the treatment of asthma; beclomethasone, a metered dose inhaler product for the asthma; and naloxone injection product candida...
Financial Performance
Financial StatementsAnalyst Forecast
According to 2 analysts, the average rating for ADMP stock is "Buy." The 12-month stock price forecast is 1.00, which is an increase of 39.80% from the latest price.
News
Top Penny Stocks For Your Under $1 List Right Now
Check these Under $1 penny stocks out for your watchlist The post Top Penny Stocks For Your Under $1 List Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Adamis Pharmaceuticals Updates Comparative Pharmacology Model Data Supporting the Higher 5 mg Intramuscular Dose of N...
Drug overdoses are the leading cause of death for those under age 50 Drug overdoses are the leading cause of death for those under age 50
Adamis Pharmaceuticals Regains Compliance with NASDAQ Continued Listing Requirements
SAN DIEGO, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and commercializing specialty products for allergy, opioid overdose...
Adamis Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Corporate Update
Management to host webcast/conference call today at 2 p.m. PT / 5 p.m. ET Management to host webcast/conference call today at 2 p.m. PT / 5 p.m. ET
Adamis Pharmaceuticals Schedules Financial Results Conference Call and Business Update
SAN DIEGO, Nov. 19, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and commercializing specialty products for allergy, opioid overdose...
Top Penny Stocks to Watch Making Big Moves Right Now
If you're making a penny stocks watchlist right now, check these three small-caps out The post Top Penny Stocks to Watch Making Big Moves Right Now appeared first on Penny Stocks to Buy, Picks, News and...
ADMP Stock: The FDA News That Has Penny Stock Adamis Pharmaceuticals Rocketing Today
Adamis Pharmaceuticals (ADMP) stock is getting a major boost on Monday thanks to a response from the U.S. Food and Drug Administration. The post ADMP Stock: The FDA News That Has Penny Stock Adamis Phar...
Penny Stocks To Watch Today As Buying Drives ADMP, IO, LPCN & Others
A jump in penny stock prices has retail traders cashing out on big gains. The post Penny Stocks To Watch Today As Buying Drives ADMP, IO, LPCN & Others appeared first on Penny Stocks to Buy, Picks, News...
Adamis Receives FDA Approval for ZIMHI
New High-Dose Naloxone Product for the Treatment of Opioid Overdose New High-Dose Naloxone Product for the Treatment of Opioid Overdose
Adamis Announces Appointment of Meera Desai, Ph.D., to Board of Directors
Appointment of New Director with Significant Experience in Drug Development, Licensing and Commercialization Appointment of New Director with Significant Experience in Drug Development, Licensing and Co...
Adamis (ADMP) Begins Dosing in COVID Oral Antiviral Study
Adamis (ADMP) starts dosing patients in phase II/III study to evaluate its oral investigational antiviral for the treatment of COVID-19.
Adamis Stock Jumps As Its Oral COVID-19 Drug Trial Starts Dosing
Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) has initiated dosing in the Phase 2/3 trial for Tempol, an oral antiviral product candidate, in adult patients with confirmed COVID-19 infection. The t...
Adamis Pharmaceuticals Doses First Patients in Phase 2/3 Clinical Trial for Tempol in the Treatment of COVID-19
SAN DIEGO, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) today announced the initiation of patient dosing in the Phase 2/3 clinical trial for Tempol, an oral antiv...
Top Penny Stocks to Watch To Stay Ahead in September 2021
Which penny stocks are on your September watchlist? The post Top Penny Stocks to Watch To Stay Ahead in September 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Trending Reddit Penny Stocks You Need to Know About Now
Reddit penny stocks are in focus following the meme stock rally; here's 3 to watch The post Trending Reddit Penny Stocks You Need to Know About Now appeared first on Penny Stocks to Buy, Picks, News and...
Adamis Announces Appointment of David C. Benedicto as Chief Financial Officer and Other Events
SAN DIEGO, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that David C. Benedicto, who has been serving as the Company's Chief Accounting Officer, wi...
Adamis Pharmaceuticals Announces a Publication with the Human Immune Monitoring Center at Stanford Demonstrating Temp...
Tempol: A potential home treatment for COVID-19 ( https://covid19.nih.gov/news-and-stories/tempol-potential-home-treatment-covid-19 ). Trial to begin shortly.
Adamis Highlights National Institutes of Health (NIH) Article Entitled, “Tempol: A Potential Home Treatment for COVID...
NIH Researchers Contend that Tempol can be taken orally and may stop the replication of the virus that causes COVID-19 NIH Researchers Contend that Tempol can be taken orally and may stop the replicatio...
Adamis Announces Agreement to Sell Portion of US Compounding Business
Transaction Proceeds Will be Used for General Corporate Purposes and Funding Intended Acceleration of Pharmaceutical Pipeline Transaction Proceeds Will be Used for General Corporate Purposes and Funding...
Adamis Announces Results of 2021 Annual Meeting of Stockholders
SAN DIEGO--(BUSINESS WIRE)--Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis” or the “Company”) today announced that based on the Inspector of Election's certified results from the Company's 2...
Adamis Urges Stockholders to Vote to Reelect the Company's Board of Directors at Upcoming Annual Meeting on Friday, J...
SAN DIEGO--(BUSINESS WIRE)--Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis” or the “Company”) today urged its valued stockholders to vote to reelect all five members of the Company's Board o...
Adamis Sends Letter to Stockholders to Address Jerald A. Hammann's Costly, Distracting and Misguided Campaign
SAN DIEGO--(BUSINESS WIRE)--Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today issued the below letter to stockholders. *** July 1, 2021 Dear Stockholders, The Board of Directors (the "Board") appr...
Adamis Sends Letter to Stockholders Regarding Its Strategic Focus on Tempol as a Potentially Potent Treatment for COV...
SAN DIEGO--(BUSINESS WIRE)--Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today issued the below letter to stockholders. June 28, 2021 Dear Stockholder, The Board of Directors (the "Board") apprecia...
Are Options Traders Betting on a Big Move in Adamis Pharmaceuticals (ADMP) Stock?
Investors need to pay close attention to Adamis Pharmaceuticals (ADMP) stock based on the movements in the options market lately.